Weesp, Netherlands

Adrianus Van Den Hoogenband


Average Co-Inventor Count = 5.3

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2006-2007

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Adrianus Van Den Hoogenband

Introduction

Adrianus Van Den Hoogenband is a notable inventor based in Weesp, Netherlands. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with neurokinin receptor antagonistic activity. With a total of 2 patents, his work has the potential to impact the treatment of various disorders.

Latest Patents

His latest patents include innovative compounds such as hexahydro-pyrido[1,2-a]pyrazine derivatives. These compounds exhibit interesting neurokinin-NK receptor antagonistic activity. The invention also encompasses methods for preparing these compounds, as well as pharmaceutical compositions containing them as active ingredients. Additionally, he has developed piperazine oxime derivatives that also demonstrate NK-1 receptor antagonistic activity. These compounds are characterized by specific structural formulas that allow for various substitutions, enhancing their therapeutic potential.

Career Highlights

Adrianus Van Den Hoogenband is associated with Solvay Pharmaceuticals B.V., where he continues to contribute to pharmaceutical innovations. His work focuses on creating novel compounds that can be utilized in treating disorders linked to neurokinin receptors. His expertise in this area has positioned him as a valuable asset in the pharmaceutical industry.

Collaborations

He has collaborated with notable colleagues such as Wouter I Iwema Bakker and Gustaaf J M Van Scharrenburg. These collaborations have likely fostered a productive environment for innovation and research within their field.

Conclusion

Adrianus Van Den Hoogenband's contributions to pharmaceutical inventions highlight the importance of innovation in developing new treatments. His patents reflect a commitment to advancing medical science and improving patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…